摘要
生物医学已进入后基因组时代。随着基因组学技术的日趋完善 ,基因标志物及相应的检测方法已逐步成为肿瘤早期诊断和风险评价的可靠依据 ,并在肿瘤的筛检工作中发挥重要的作用。
出处
《国外医学(生理病理科学与临床分册)》
2003年第6期561-563,共3页
Foreign Medical Sciences(Pathophysiology and Clinical Medicine)
基金
卫生部部属 (管 )医院临床学科重点项目 ([2 0 0 1] 3 2 1)
参考文献16
-
1Pollak MN, Foulkes WD. Challenges to cancer control by screening[ J ]. Nat Rev Cancer, 2003,3 ( 4 ) :297-303.
-
2Smith RA, Cokkinides V, Eyre HJ. American cancer society guidelines for the early detection of cancer, 2003 [ J ]. CA Cancer J Clin,2003, 53(1) :27-43.
-
3Alaiya AA, Franzen B, Auer G, et al . Cancer preoteomics:From identification of novel markers to creation of artifical learning models for tumor classification [ J ]. Electrophoresis, 2000, 21 ( 6 ): 1210.
-
4Laird PW. The power and the promise of DNA methylation markers[J]. Nat Rev Cancer, 2003, 3(4) :253-266.
-
5Inai M, Kano M, Shimada Y, Telomerase activity of the Lugolstained and -unstained squamous epithelia in the process of oesophageal carcinogenesis[ J ]. Br J Cancer,2001,85 (7): 1006-1013.
-
6Parrella P, Xiao Y, Fliss M, et al . Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspiratesl[J]. Cancer Res, 2001,61(20) :7623-7626.
-
7Kram A, Li L, Zhang RD, et al . Mapping and genome sequence analysis of chromosome 5 regions involved in bladder cancer progression[J]. Lab Invest, 2001 , 81 (7) :1039-1048.
-
8Yoon DS, Li L, Zhang RD, et al . Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease [ J ]. Oncogene, 2001,20 (36) :5005 - 5014.
-
9Mori Y, Yin J, Rashid A, et al. Instabilotyping: Comprehensive identification of frameshift mutations caused by coding region microsatellite instability[ J]. Cancer Res,2001,61 (16) :6046-6049.
-
10Maitrat A, Wistuba LL, Washinton C, et al . High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss [ J ]. Am J Pathol,2001,159 ( 1 ): 119-130.
同被引文献16
-
1黄德寅,刘琦,王卉,龙翔云.尿脱落细胞检查在联苯胺作业工人健康监护中的作用[J].职业卫生与应急救援,2004,22(2):59-60. 被引量:1
-
2葛宪民,陈晓琴,陈婷婷,苏素花,翟日洪,周少诗,甘永金.铅镉铝砷苯及X射线致淋巴细胞染色单体互换畸变的特性研究[J].广西医科大学学报,2004,21(4):472-475. 被引量:2
-
3龙耀庭.生物大分子(DNA及蛋白质)加和物的质谱分析鉴别[J].环境科学,1995,16(6):79-82. 被引量:3
-
4Lee A J, Hodges N J, Chipman J K. Interindividual variability in response to sodium dichromate-induced oxidative DNA damage: role of the S, er326Cys polymorphism in the DNA-repair protein of 8-oxo- 7, 8-dihydro-2'-deoxyguanosine DNA glycosylase 1 [ J ]. Cancer Epidemiol Biomarkers Prey, 2005, 14: 497-505.
-
5Setlow R B. Variations in DNA repair among humans//Harris CC, Autrp HN, ed, Human carcinogenesis[M]. New York: Academic Press, 1983: 231-254.
-
6Pavanello Sofia, Pulliero Alessandra, Siwinska Ewa, et al. Reduced nucleotide excision repair and GSTM1-null genotypes influence anti-B[a] PDE-DNA adduct levels in mononuclear white blood cells of highly PAH-exposed coke-oven workers [ J ]. Carcinogenesis, 2005, 26 (1): 169-175.
-
7Bodell W J, Levay G, Pongracz K. Investigation of benzene DNA adducts and their detection in human bone marrow [ J ]. Environ Health Perspect, 1993, 99: 241-244.
-
8Paul W, Brandt-Rauf. New Markers for monitoring occupational cancer: The example of oncogene [ J ]. Journal of Occupational Medicine, 1998, 30 (5): 399.
-
9Harem R D. Occupational cancer in the oncogene era [J]. Brit Industr Med, 1990, 47: 217.
-
10Barbone F, Bovenzi M, Cavalliei F, et al. Cigarette smoking and histolog~ctype of lung cancer in men [J]. Chest, 1997, 112 (6) : 1474-1479.
-
1郭鹏,介评.Cell Reports:肾细胞癌分子分型——基于多水平的基因组学技术[J].现代泌尿外科杂志,2016,21(4):310-310.
-
2杨雪琴,李雁.胃癌、结直肠癌相关血清肿瘤标志物研究进展[J].军医进修学院学报,2009,30(5):745-747. 被引量:3
-
3侯振江.基因标志物在肺癌预后监测中的应用[J].临床肺科杂志,2004,9(6):668-669. 被引量:3
-
4郑航,罗荣城.基因标志物与乳腺癌的预后关系[J].中国临床医学,2004,11(2):142-143. 被引量:2
-
5庾少俸.基因标志物在急性白血病的应用[J].中外妇儿健康(学术版),2011,19(3):97-97.
-
6韩万凤,钱哨,刘博.基因标志物与子宫内膜癌预后因素的研究进展[J].中国煤炭工业医学杂志,2006,9(4):301-303.
-
7侯振江,张丽华.基因标志物与大肠癌预后[J].中国肛肠病杂志,2005,25(4):53-55. 被引量:1
-
8薛开先.肿瘤分子流行病学——肿瘤易感性、风险评价与预防[J].癌变·畸变·突变,2000,12(1):63-64. 被引量:1
-
9肿瘤分子流行病学——肿瘤易感性、风险评价与预防(续)[J].癌变·畸变·突变,2000,12(2):127-128.
-
10肿瘤分子流行病学——肿瘤易感性、风险评价与预防(续)[J].癌变·畸变·突变,2000,12(3):191-191.